In an animal model of anal sarcoma, the researchers used APS instead of TNF-α to induce maturation of bone marrow-derived DCs, which were then sensitized with the S180 tumor antigen, thereby obtaining a DC tumor vaccine. This evidence concerns the gene TNF and neoplasm.